Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kristin Josic"'
Autor:
Cynthia R. Stockdale, Janis T. Eells, Daniel F. Martin, Adam R. Glassman, Hani Salehi-Had, Dennis M. Marcus, Timothy S. Kern, Lee M. Jampol, Michele Melia, Jennifer K. Sun, Sandeep N. Shah, Judy E. Kim, Carl W. Baker, Lloyd Paul Aiello, Kristin Josic
Publikováno v:
Ophthalmol Retina
Purpose To determine if treatment with a photobiomodulation (PBM) device results in greater improvement in central subfield thickness as compared with placebo in eyes with center-involved diabetic macular edema (CI-DME) and good vision Design Phase 2
Autor:
Carl W. Baker, Kristin Josic, Maureen G. Maguire, Lee M. Jampol, Daniel F. Martin, Soraya Rofagha, Jennifer K. Sun
Publikováno v:
Ophthalmology.
Evaluate the differences between clinical visual acuity (VA) as recorded in medical records and electronic ETDRS (eETDRS) protocol VA measurements and factors affecting the size of the differences.Retrospective chart review.Study and fellow eyes of p
Autor:
Raj K. Maturi, Adam R. Glassman, Daniel F. Martin, Michele Melia, Dennis M. Marcus, Jennifer K. Sun, Barbara A Blodi, Kristin Josic, Andrew N. Antoszyk, Hani Salehi-Had, Omar S. Punjabi, Lee M. Jampol, Cynthia R. Stockdale
Publikováno v:
JAMA Ophthalmol
IMPORTANCE: The role of anti–vascular endothelial growth factor injections for the management of nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) has not been clearly established. OBJECTIVE: To de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c074f5e07d0316edccb435e3a23518c
https://europepmc.org/articles/PMC8010644/
https://europepmc.org/articles/PMC8010644/
Autor:
Andrew N. Antoszyk, Kristin Josic, Michael J. Elman, Adam R. Glassman, John A. Wells, Maureen G. Maguire, Wesley T. Beaulieu, Lee M. Jampol, Jennifer K. Sun, Carl W. Baker
Publikováno v:
Ophthalmology
Purpose Assess follow-up treatment and clinical outcomes at 5 years in eyes initially treated with anti-VEGF therapy for center-involved diabetic macular edema (CI-DME) in a 2-year randomized clinical trial. Design Multicenter cohort study. Participa